WTA
BSX icon

Washington Trust Advisors’s Boston Scientific BSX Stock Holding History

Washington Trust Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.6K Buy
1,508
+46
+3% +$3.68K 0.01% 296
2025
Q4 		$139K Buy
1,462
+1,312
+875% +$129K 0.01% 249
2025
Q3 		$14.6K Sell
150
-60
-29% -$6.21K ﹤0.01% 477
2025
Q2 		$22.6K Sell
210
-542
-72% -$54.8K ﹤0.01% 390
2025
Q1 		$75.9K Sell
752
-75
-9% -$7.55K 0.01% 278
2024
Q4 		$73.9K Hold
827
– – 0.01% 290
2024
Q3 		$69.3K Sell
827
-104
-11% -$8.2K 0.01% 291
2024
Q2 		$71.7K Buy
931
+159
+21% +$11.6K 0.01% 277
2024
Q1 		$52.9K Sell
772
-165
-18% -$10.6K ﹤0.01% 311
2023
Q4 		$54.2K Sell
937
-109
-10% -$5.82K 0.01% 299
2023
Q3 		$55.2K Buy
1,046
+35
+3% +$1.84K 0.01% 290
2023
Q2 		$54.7K Buy
1,011
+630
+165% +$32.9K 0.01% 286
2023
Q1 		$19.1K Hold
381
– – ﹤0.01% 424
2022
Q4 		$17.6K Sell
381
-903
-70% -$39.1K ﹤0.01% 437
2022
Q3 		$50K Buy
1,284
+845
+192% +$33.9K ﹤0.01% 385
2022
Q2 		$16K Buy
439
+317
+260% +$12.9K ﹤0.01% 568
2022
Q1 		$5K Sell
122
-211
-63% -$9.14K ﹤0.01% 811
2021
Q4 		$14K Buy
+333
New +$14K ﹤0.01% 681

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Washington Trust Advisors's BSX Position: Q1 2026 in Review

Washington Trust Advisors increased its Boston Scientific (BSX) stake by 3.1% in Q1 2026, buying an estimated $3.68K and bringing the position to 1,508 shares worth $94.6K. The position accounts for 0.01% of the portfolio, ranked #296.

Washington Trust Advisors first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $139K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Washington Trust Advisors held 1,508 shares of Boston Scientific worth $94.6K as of Q1 2026.
  • Washington Trust Advisors bought 46 Boston Scientific shares in Q1 2026, an estimated $3.68K.
  • Boston Scientific made up 0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #296 holding.
  • Washington Trust Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
  • Washington Trust Advisors's Boston Scientific position peaked at $139K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.